Nephros Announces $2.9 Million Private Placement

SOUTH ORANGE, NJ, April 11, 2018 (GLOBE NEWSWIRE) Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), today announced that it has completed a private placement in which it sold approximately 6.5 million shares of common stock at a purchase price of $0.45 per share, The post Nephros Announces $2.9 Million Private Placement appeared first on Public Wire.
http://bit.ly/2GSxAlQ